ERcast: Clinical Perspectives Podcast Preview

Subscription Required

Lit Matters 3: Moderate HEART Scores With/Without CAD

Matthew DeLaney, MD, FACEP, FAAEM and Charles Khoury MD, FACEP, FAAEM

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Moderate HEART scores do not all carry the same ACS risk. In possible acute coronary syndrome, a patient with HEAR 4 or higher, negative serial troponins, a nonischemic ECG, and no prior coronary artery disease had a low 30-day MACE rate in this study.

Moderate HEART Score Risk Stratification

  • Prior CAD as discriminator: Known coronary artery disease meaningfully changes post-test risk: among moderate-risk patients, 30-day MACE was 7.1% with prior CAD versus 1.4% without it.
  • True moderate-risk definition: The study’s moderate-risk group was not troponin-positive ACS; it was HEAR score 4 or higher with negative 0- and 3-hour troponins and a nonischemic ECG.
  • Objective testing rethink: Moderate-risk patients without prior CAD may not need routine objective coronary testing after ED evaluation, a disposition nuance we get into in the episode.
  • Negative likelihood ratio signal: In moderate-risk patients without prior CAD, the negative likelihood ratio for 30-day MACE was 0.08, a rule-out signal strong enough to support discharge conversations.
  • Missed-event context matters: Several adverse events in the no-CAD group were tied to protocol violations, noncardiac death, or revascularization without MI, an important caveat behind the headline reassurance.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

Faculty